• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

ReShape Lifesciences

MedTech 100 roundup: Another peak for the industry

January 25, 2021 By Sean Whooley

Medtech stocks have been on the rise in 2021, and the past week saw the trend continue with yet another all-time best mark. MassDevice‘s MedTech 100 index reached 107.4 points on Jan. 20, topping the all-time best of 106.81 points set on Jan. 8. That mark represents a 16% jump from the pre-pandemic high of 92.32 […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Abbott, Amazon, Bardy Diagnostics, Boston Scientific, Cardiva Medical Inc., coronavirus, COVID-19, COVID-19 vaccine, GE Healthcare, Haemonetics, Hillrom, Intuitive Surgical, Joe Biden, MedTech 100 Index, Mesa Biotech, Obalon Therapeutics, Philips, Preventice, ReShape Lifesciences, Thermo Fisher Scientific

ReShape Lifesciences slides on Q2 losses

August 14, 2020 By Sean Whooley

ReShape Lifesciences (OTC:RSLS) shares took a hit yesterday on second-quarter results that highlighted big losses. The San Clemente, Calif.-based obesity and metabolic disease treatment developer posted losses of -$3.6 million, or -52¢ per share, on sales of $1.7 million for the three months ended June 30, 2020, for a 77% bottom-line gain on a sales decline […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat, Weight loss Tagged With: ReShape Lifesciences

ReShape loses profits, grows sales in Q3

November 15, 2019 By Sean Whooley

ReShape Lifesciences (OTC:RSLS) posted large bottom-line losses in the third quarter, despite a big leap in sales growth. The San Clemente, Calif.–based obesity and metabolic disease treatment developer posted losses of -$28.8 million, or $-106.55 per share, on sales of $3.5 million for the three months ended Sept. 30, for a massive bottom-line slide on […]

Filed Under: MassDevice Earnings Roundup, Wall Street Beat, Weight loss Tagged With: ReShape Lifesciences

Biomet vet Serbousek to succeed Mason as Orthofix CEO | Personnel Moves, August 13, 2019

August 13, 2019 By Brad Perriello

Orthofix (NSDQ:OFIX) last week named a successor for president & CEO Brad Mason in November, tapping Jon Serbousek as president of its spine business effective August 5. Mason is slated to retire Oct. 31; Serbousek, a 30-year medtech veteran with stints at Biomet, Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) unit DePuy Orthopaedics, is due to […]

Filed Under: Business/Financial News, Featured Tagged With: Accuray Inc., Bill & Melinda Gates Foundation, CeloNova BioSciences, Corinth MedTech, MiMedx Group Inc., Nimbus Concepts, On Target Labs, Orthofix, Personnel Moves, Ra Medical, ReShape Lifesciences, Second Sight, Stryker, Virginia Bio

Apollo Endosurgery beats on Q2 sales, misses on earnings

July 24, 2019 By Nancy Crotti

Apollo Endosurgery (NSDQ:APEN) reported second-quarter results yesterday that beat analysts’ expectations for sales but missed on earnings. The Austin, Texas-based company reported a net loss of -$8.8 million, or -40¢ per share, on sales of $14.3 million for the three months ended June 30. Analysts on Wall Street were looking for losses per share of […]

Filed Under: Blog, Business/Financial News, Endoscopic, News Well, Wall Street Beat Tagged With: Apollo Endosurgery, ReShape Lifesciences

Apollo Endosurgery updates labeling on intragastric balloon

June 14, 2019 By Nancy Crotti

Apollo Endosurgery (NSDQ:APEN) said today that the FDA has approved its proposed labeling updates for the Orbera intragastric liquid-filled balloon system, which is used to treat obesity. The goal of the labeling updates is to improve patient safety and they will take effect immediately, according to the Austin, Texas-based company. The Orbera system and Reshape […]

Filed Under: Endoscopic, Featured, Food & Drug Administration (FDA), News Well, Regulatory/Compliance, Weight loss Tagged With: Apollo Endosurgery, FDA, ReShape Lifesciences

ReShape taps Allergan vet Bandy for CEO | Personnel Moves, April 3 2019

April 3, 2019 By Brad Perriello

ReShape Lifesciences (NSDQ:RSLS) said last week that it named Allergan (NYSE: AGN) veteran Barton Bandy to replace Dan Gladney in the corner office, effective April 1. Gladney, who announced his retirement in January, is staying on as chairman. Bandy spent a decade at Inamed until its $3.2 billion purchase by Allergan in 2005. “I am […]

Filed Under: Business/Financial News, Featured Tagged With: Alcon, Bio-Rad, Dept. of Health & Human Services (HHS), ExsoMed, FDA, iCad Inc., McKesson, Novartis, Personnel Moves, polarityte, ReShape Lifesciences, Stryker

ReShape Lifesciences CEO Gladney to resign | Personnel Moves – January 29, 2019

January 29, 2019 By Fink Densford

ReShape Lifesciences (NSDQ:RSLS) said yesterday that its prez & CEO Dan Gladney will resign from his positions with the company, effective March 31. Gladney will remain with the company as board chair, San Clemente, Calif.-based ReShape Lifesciences said. The company’s board of directors said they will immediately begin to look for a replacement, according to an […]

Filed Under: Business/Financial News, Featured Tagged With: Adherium Limited, AliveCor, AxoGen, Biocoat, Cardinal Health, Cirtec Medical, Functional Neuromodulation, georgiabio, iCad Inc., Ra Medical, ReShape Lifesciences, SPR Therapeutics, vasculardynamics

Apollo Endosurgery deals Lap-Band to ReShape Lifesciences for up to $17m

December 18, 2018 By Brad Perriello

Apollo Endosurgery (NSDQ:APEN) said today that it dealt its Lap-Band gastric banding device to ReShape Lifesciences (NSDQ:RSLS) in return for up to $17 million and ReShape’s intra-gastric balloon, which Apollo plans to eventually discontinue. Austin, Texas-based Apollo said the exchange closed yesterday with $10 million in cash and the balloon from ReShape. Further payments of $2 […]

Filed Under: Featured, Mergers & Acquisitions, Wall Street Beat, Weight loss Tagged With: Apollo Endosurgery, ReShape Lifesciences

Reshape Lifesciences settles with institutional investors for $700K

November 29, 2018 By Chris Newmarker

Just days after it announced that it had raised $10 million in a registered direct offering, ReShape Lifesciences (NSDQ:RSLS) disclosed in a regulatory filing that it’s paying $350,000 to each of the two institutional investors involved. The U.S. Securities and Exchange Commission filing, dated yesterday, said the money settles a dispute that arose prior to the closing […]

Filed Under: Business/Financial News, Featured, News Well Tagged With: ReShape Lifesciences

ReShape Lifesciences shares plunge on Q2 release, withdrawn offering

August 15, 2018 By Fink Densford

Shares in ReShape Lifesciences (NSDQ:RSLS) have fell 30% today after the weight loss device maker posted second quarter earnings that missed expectations on Wall Street and announced it terminated plans for an upcoming offering. The San Clemente, Calif.-based company posted losses of $35.3 million, or $14.23 per share, on sales of $653,369 for the three months […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: ReShape Lifesciences

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy